Adial Pharmaceuticals (ADIL) Metrics: History & Chart

Adial Pharmaceuticals, Inc.(ADIL)

Biotechnology · Glen Allen, VA

$3.98-0.37 (-8.51%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.

Glen Allen, VA

5 employees

www.adial.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Cary John Claiborne

View full financials

Third-Party DCF Estimate (FMP)	$7.97
Price Gap vs Third-Party Estimate	+83.31%

7D Total Return	+7.67%
30D Total Return	-38.90%
YTD Total Return	-20.91%
1Y Total Return	-56.50%
3Y Total Return	-93.72%
5Y Total Return	-99.82%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-20.91%
2025	-78.22%
2024	-45.70%
2023	-66.18%
2022	-91.85%
2021	+58.82%
2020

CAGR TTM	-56.33%
CAGR 3Y	-60.24%
CAGR 5Y	-71.86%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

ADIL Valuation Metrics

ADIL Stock Price Metrics

ADIL Dividend Metrics

ADIL Growth Rate Metrics

ADIL Discounted Cash Flow Metrics

ADIL Returns By Period

ADIL Yearly Returns

ADIL Average Annual Returns By Period (CAGR)

ADIL Revenue Metrics

ADIL PE Ratio Metrics

ADIL PS Ratio Metrics

ADIL PB Ratio Metrics

ADIL Price to Free Cash Flow Ratio Metrics

ADIL Debt to Equity Ratio Metrics

ADIL PEG Ratio Metrics

ADIL FCF Yield

ADIL Earnings Yield

ADIL EBITDA Yield

ADIL OCF Yield

ADIL EV/EBIT Ratio Metrics

ADIL EV/EBITDA Ratio Metrics

ADIL EV/Assets Ratio Metrics

ADIL EV/Sales Ratio Metrics

ADIL Current Ratio Metrics

ADIL Quick Ratio Metrics

ADIL ROIC Metrics

ADIL Return on Assets Metrics

ADIL Return on Equity Metrics

ADIL Net Profit Margin Metrics

ADIL Gross Profit Margin Metrics

ADIL Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	1.47
PB Ratio Avg TTM	0.83
PB Ratio Avg 3Y	0.86
Current VS TTM Avg	+76.92%
Current VS 3Y Avg	+70.63%
Current VS 5Y Avg	-19.13%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.07
Ev/Assets Ratio Avg TTM	0.20
Ev/Assets Ratio Avg 3Y	0.63
Current VS TTM Avg	-65.52%
Current VS 3Y Avg	-88.92%
Current VS 5Y Avg	-92.85%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	5.63
Current Ratio Avg TTM	4.52
Current Ratio Avg 3Y	4.39
Current VS TTM Avg	+24.62%
Current VS 3Y Avg	+28.28%
Current VS 5Y Avg	+36.74%

Quick Ratio	5.63
Quick Ratio Avg TTM	4.52
Quick Ratio Avg 3Y	4.39
Current VS TTM Avg	+24.62%
Current VS 3Y Avg	+28.28%
Current VS 5Y Avg	+36.74%

ROIC	(240.64%)
ROIC Avg 3Y	(191.18%)
ROIC Avg 5Y	(220.73%)
Current VS 3Y Avg	-25.87%
Current VS 5Y Avg	-9.02%
Current VS 10Y Avg	-23.64%

ROA	(198.70%)
ROA Avg TTM	(61.45%)
ROA Avg 3Y	(40.53%)
Current VS TTM Avg	-223.34%
Current VS 3Y Avg	-390.21%
Current VS 5Y Avg	-347.73%

ROE	(37052.06%)
ROE Avg TTM	(222.19%)
ROE Avg 3Y	(225.43%)
Current VS TTM Avg	-16576.10%
Current VS 3Y Avg	-16335.86%
Current VS 5Y Avg	-15307.73%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.13%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-100.00%